G

Genpharmasec Ltd
BSE:531592

Watchlist Manager
Genpharmasec Ltd
BSE:531592
Watchlist
Price: 2.14 INR -1.83% Market Closed
Market Cap: 1.2B INR

Intrinsic Value

531592 price has not been updated for more than 2 years. This may indicate that the stock has been delisted.
531592 doesn't have a meaningful market cap.

The intrinsic value of one GENPHARMA stock under the Base Case scenario is 0.82 INR. Compared to the current market price of 2.14 INR, Genpharmasec Ltd is Overvalued by 62%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GENPHARMA Intrinsic Value
0.82 INR
Overvaluation 62%
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case

Valuation History
Genpharmasec Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
GENPHARMA
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for GENPHARMA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Genpharmasec Ltd
BSE:531592
IN
Trading Companies & Distributors
Market Cap
1.1B INR
IPO
Feb 5, 1996
IN
Trading Companies & Distributors
Market Cap
1.1B INR
IPO
Feb 5, 1996
Price
â‚ąfalse
EPS
â‚ąfalse
Company Overview
Loading...
Contacts
Loading...
How do you feel about GENPHARMA?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Genpharmasec Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Genpharmasec Ltd

Current Assets 217m
Cash & Short-Term Investments 38.2m
Receivables 58.3m
Other Current Assets 120.5m
Non-Current Assets 536.8m
Long-Term Investments 194m
PP&E 63m
Other Non-Current Assets 279.8m
Efficiency

Free Cash Flow Analysis
Genpharmasec Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Genpharmasec Ltd

Revenue
299.1m INR
Cost of Revenue
-237.6m INR
Gross Profit
61.5m INR
Operating Expenses
-56.5m INR
Operating Income
5m INR
Other Expenses
10.4m INR
Net Income
15.5m INR
Fundamental Scores

GENPHARMA Profitability Score
Profitability Due Diligence

Genpharmasec Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Positive 1-Year Revenue Growth
Positive 3-Years Revenue Growth
Positive Gross Profit
Low ROE
37/100
Profitability
Score

Genpharmasec Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

GENPHARMA Solvency Score
Solvency Due Diligence

Genpharmasec Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
70/100
Solvency
Score

Genpharmasec Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GENPHARMA Price Targets Summary
Genpharmasec Ltd

There are no price targets for GENPHARMA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Genpharmasec Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for GENPHARMA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one GENPHARMA stock?

The intrinsic value of one GENPHARMA stock under the Base Case scenario is 0.82 INR.

Is GENPHARMA stock undervalued or overvalued?

Compared to the current market price of 2.14 INR, Genpharmasec Ltd is Overvalued by 62%.

Back to Top